NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...

Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...

Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...

Federal budget cuts this week have undercut research at the University of Minnesota that was closing in on a better COVID-19 antiviral therapy and first-ever treatments for Ebola and other threatening ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

People who started taking the antiviral drug ensitrelvir within 72 hours after ... ensitrelvir is approved in Japan for the ...

Trump’s administration this week abruptly terminated funding for a slew of studies designed to learn how to better treat the ...

The US National Institutes of Health (NIH) appears to be reversing course on its decision to abruptly cancel a spate of grants for long COVID research earlier this week. This site uses cookies to ...

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...

Mr Cawley added: "Ultimately I've lost my job because of long Covid, and I'm also having to sell my house because I'm not in ...